Advertisement

Topics

Outlook Therapeutics nets $26.8mm via FOPO

15:40 EDT 15 Apr 2019 | Elsevier Business Intelligence

Ophthalmic-focused Outlook Therapeutics Inc. (formerly Oncobiologics) netted $26.8mm through a follow-on offering of 10.34mm ...

Original Article: Outlook Therapeutics nets $26.8mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "Outlook Therapeutics nets $26.8mm via FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...